Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stocks On The Move: ACHN, CLDX, OREX, TASR

Published 12/18/2014, 01:09 AM
Updated 07/09/2023, 06:31 AM

Stocks On The Move: ACHN, CLDX, OREX, TASR

The stock market had a wonderful session on Wednesday, and we had some beauties early on that did extremely well. Congratulations Tech Traders! It was a good day, indeed! Let’s take a look at some of our stocks, recent swing trades, and day trades we put out on Wednesday.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) was up nearly 10% on Wednesday. I love the way it’s been holding support. The 50-day moving average is right at $12.24.

The low on Tuesday was $12.41, and on Wednesday it popped from $12.92 to $14.21, and closed just a penny off the high at $14.20, up $1.28.

That was a fabulous close. The volume picked up to 4.7 million shares traded. What we need is for it to rise above $15.31, and then I’m looking at $19.00.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) had a nice snap-back on Wednesday, going from $16.60 to $18.14, and closed only 4 cents off the high at $18.10, up $1.27, or 7.5%, on 1.7 million shares. There is still some resistance here, and it has not taken out the pattern yet.

The orderly channel has taken this stock down over a 3-week period from the $21.70 area, all the way back down to $16, and changed, right around the 50-day and lateral support. That was a nice snap-back.

Can it get a follow-through? What is key to me is that it takes out the moving averages and then rises again near the $19.00 range. That was good volume for this stock, but I want to see better volume, up to 5-10 million shares. It may very well get that.

The targets will be a retest of the highs around $21.70, then $23, and then $27 potentially, particularly if it’s breaking out of a base. There’s the breakaway gap. And you know how I am about the first pullback after a breakout. Right to the moving average. It could be an ideal candidate right now, of course, with a stop under $16.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) had a nice pop late in the day on Wednesday, up 47 cents, or 8%, on nearly 4 million shares. It has been going in fits and starts and really had disappointed a little bit in that it’s gone on longer than I wanted. When you see a pop, pullback, and pop, a consolidation is expected. As soon as volume came in, this stock exploded.

I want to see a follow-through. If it gets through the spike-high at around $6.50, it could reach $7.50-$7.75 pretty quickly, and that’s my first swing-trade target. Then afterwards, $11.50-$11.75. It’s 4 waves up, the fifth wave should take it to about $7.75, and then we’ll see what happens next.

TASER International Inc. (NASDAQ:TASR) did great on Wednesday, up $1.76, or 7.7%, on 5.8 million shares. If you take a look at the wedge, it was forming inside the channel. It’s a beautiful rising channel, indeed, folks. It has four waves up. The fifth way may be beginning. I’m looking for this to get to $28, and then $32-$33.

Other stocks on Harry’s Charts of the Day: Agios Pharmaceuticals, Inc.(NASDAQ:AGIO), Cerus Corporation (NASDAQ:CERS), Green Brick Partners, Inc.(NASDAQ:GRBK), Groupon, Inc.(NASDAQ:GRPN), Oasis Petroleum Inc.(NYSE:OAS), Organovo Holdings, Inc.(NYSE:ONVO), and Intrexon Corporation (NYSE:XON).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.